Table 3 Distribution of 25(OH)D3 levels before and after supplementation according to gender (%)
Severe deficiency | Deficiency | Suboptimal | Optimal | |||||
|---|---|---|---|---|---|---|---|---|
0–10 ng/ml | > 10–20 ng/ml | > 20–30 ng/ml | > 30–50 ng/ml | |||||
Baseline | After 3 months of supplementation | Baseline | After 3 months of supplementation | Baseline | After 3 months of supplementation | Baseline | After 3 months of supplemetation | |
Male | 23.53 | 0 | 35.29 | 5.88 | 41.18 | 47.06 | 0 | 47.06 |
Female | 6.25 | 0 | 43.75 | 6.25 | 50.00 | 50.00 | 0 | 43.75 |